- Company reiterates key pipeline and strategic milestones for 2022 – TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (NYSE American:CYBN) (“Cybin” or the “Company”), a biopharmaceutical company focused on progressing “Psychedelics to Therape
IMV achieves predetermined milestone to access the remaining $US10 Million under its Debt Facility with Horizon Phase 2b AVALON trial in platinum-resistant ovarian cancer open for enrollment DARTMOUTH, Nova Scotia & CAMBRIDGE, Mass.--(BUSINESS WIRE)--IM
VANCOUVER, British Columbia--(BUSINESS WIRE)--Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating neurodegenerati
WINNIPEG, Manitoba--(BUSINESS WIRE)--Ag Growth International Inc. (TSX: AFN) (“AGI” or the “Company”) today announced the declaration of a cash dividend of $0.15 per common share for the second quarter ending June 30, 2022. The dividend is payable
VANCOUVER, British Columbia--(BUSINESS WIRE)--Eat Well Investment Group Inc. (CSE: EWG) (US: EWGFF) (FSE: 6BC0) (“Eat Well” or the “Company”) announces its intention to proceed with a normal course issuer bid (“NCIB”) for up to 7,686,777 commo
Company will focus on untapped demographic groups that value aesthetics and a new definition of luxury TORONTO--(BUSINESS WIRE)--First paragraph, first sentence of release should read: Croma Aesthetics Canada Ltd., doing business as Hugel Aesthetics is
Platform Radically Streamlines Controlled Environment Agriculture Operations TORONTO & PALO ALTO, Calif.--(BUSINESS WIRE)--#AIinfarming--Raiven Capital, a global early-stage tech venture fund, today announced its investment in Vancouver-based Elevated Si
MISSISSAUGA, Ontario--(BUSINESS WIRE)--$MDX #SkinCancer--MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, is pleased to announce that it has received final Acceptance from the TSX Venture Exchange in res
– Preclinical data show synergistic protective effect of anti-protein and anti-polysaccharide antibodies in a highly virulent model of serotype 3 invasive pneumococcal disease – – Presentation at the 12th International Symposium on Pneumococci and
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES SASKATOON, Saskatchewan & LONDON--(BUSINESS WIRE)--SASKATOON, Saskatchewan and London, U.K., June 21, 2022 – Gensource Potash Corporation (“Gensource” or the “C
Dr. Waylon Hunt took an unusual path to co-founding and leading a lab-based business, Intrinsic Analytics.
With a burgeoning scientific portfolio showing a unique ability to boost Akkermansia and Bifidobacteria levels, new products launching before the end of 2023, and international regulatory approvals, Solnul resistant starch “is primed to further penetrate
ElevateIP is a program funded by the Government of Canada aimed at equipping and supporting Canadian start-ups with the tools and knowledge to understand, strategize, protect, manage and leverage their intellectual property (IP)
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.